Squarepoint’s Acadia Healthcare ACHC Stock Holding History

Squarepoint’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-13,100	Closed	-$297K	–	4306
2025 Q2	$297K	Buy	+13,100	New	+$310K	﹤0.01%	3691

Other funds holding ACHC

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Natixis Paris, France $28B AUM 27.03% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Penn Capital Management Philadelphia, Pennsylvania $1.37B AUM 42.56% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Squarepoint's ACHC Position: Q3 2026 in Review

Squarepoint sold out of Acadia Healthcare (ACHC) in Q3 2026, closing a stake of 10,331 shares — an estimated $305K sold.

Squarepoint first reported a position in ACHC in Q4 2015 and held it in 25 quarters. The position peaked at $4.47M in Q4 2025. 128 funds tracked by Wall St. Rank hold ACHC as of Q3 2026.

Squarepoint reported no remaining Acadia Healthcare position as of Q3 2026 after selling out during the quarter.
Squarepoint sold 10,331 Acadia Healthcare shares in Q3 2026, an estimated $305K.
Squarepoint first reported a position in Acadia Healthcare in Q4 2015 and held it in 25 quarters.
Squarepoint's Acadia Healthcare position peaked at $4.47M in Q4 2025.
128 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.